These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 918143)

  • 1. MAO activity in rat brain stem and cerebral cortex following acute and chronic treatment with L-dopa and ethanol + L-dopa.
    Renis M; Giovine A; Bertolino A
    Pharmacology; 1977; 15(5):392-9. PubMed ID: 918143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAO activity in rat brain stem and cerebral cortex: effect of acute and chronic treatment with ethanol and tetrahydropapaveroline.
    Renis M; Giovine A; Bertolino A
    Pharmacology; 1978; 17(1):1-7. PubMed ID: 684069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms of regulating monoamine oxidase activity in different brain regions].
    Petrenko SV; Balakleevskiĭ AI
    Vopr Med Khim; 1980; 26(2):264-70. PubMed ID: 7456358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of benserazide on changes in monoamine oxidase activity in some rat tissues following treatment with L-DOPA.
    Callingham BA; Lyles GA
    J Auton Pharmacol; 1980 Nov; 1(1):9-16. PubMed ID: 7341636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin of dopamine in the rat adrenal cortex.
    Buu NT; Lussier C
    Am J Physiol; 1990 Feb; 258(2 Pt 2):F287-91. PubMed ID: 2106792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicular accumulation of dopamine following L-DOPA administration.
    Buu NT
    Biochem Pharmacol; 1989 Jun; 38(11):1787-92. PubMed ID: 2735936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of monoamine oxidase maturation in mouse brain.
    Baker PC; Hoff KM; Samsa JM
    Biol Neonate; 1983; 43(1-2):67-71. PubMed ID: 6850015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of L-DOPA pharmacological activity by MAO inhibitors.
    Finberg JP; Sader-Mazbar O
    J Neural Transm (Vienna); 2007; 114(6):801-5. PubMed ID: 17417741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes induced by ethanol in monoamine oxidase activity in the rat's brain mitochondria: MAO-DA and MAO-NA].
    Renis M; Giovine A; Bertolino A
    Acta Neurol (Napoli); 1974; 29(3):293-8. PubMed ID: 4422384
    [No Abstract]   [Full Text] [Related]  

  • 12. Modification of dopamine and norepinephrine metabolism in the rat brain by monoamine oxidase inhibitors.
    Buu NT; Angers M; Duhaime J; Kuchel O
    J Neural Transm; 1987; 70(1-2):39-50. PubMed ID: 3668521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of monoamine oxidase-B in medroxyprogesterone acetate (17-acetoxy-6 alpha-methyl-4-pregnene-3, 20-dione) induced changes in brain dopamine levels of rats.
    Tandon P; Gupta ML; Barthwal JP; Gupta TK; Parmar SS; Bhargava KP
    Steroids; 1983 Sep; 42(3):231-9. PubMed ID: 6231746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of levels of biogenic amines and their metabolites and both forms of monoamine oxidase in prefrontal cortex of aged rats.
    Venero JL; Machado A; Cano J
    Mech Ageing Dev; 1990 Dec; 56(3):253-63. PubMed ID: 2089199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of acute and chronic ethanol consumption on rat brain and liver monoamine oxidase activity].
    Romanova LA
    Vopr Med Khim; 1980; 26(2):252-5. PubMed ID: 7192903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of L-dopa administration on islet monoamine oxidase activity and glucose-induced insulin release in the mouse.
    Lundquist I; Panagiotidis G; Stenström A
    Pancreas; 1991 Sep; 6(5):522-7. PubMed ID: 1946308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic cadmium-ethanol administration alters metal distribution and some biochemicals in rat brain.
    Murthy RC; Saxena DK; Lal B; Chandra SV
    Biochem Int; 1989 Jul; 19(1):135-43. PubMed ID: 2775298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interactions of cerebral serotonin and catecholamines].
    Watanabe Y
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):365-83. PubMed ID: 6195056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glaucine and some glaucine derivatives and of their combination with L-DOPA on the brain level of biogenic monoamines.
    Petkov V; Yanev S; Stancheva S
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):83-92. PubMed ID: 7181577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional changes in [3H]-noradrenaline uptake, catecholamines and catecholamine synthetic and catabolic enzymes in rat brain following neonatal 6-hydroxydopamine treatment.
    Jonsson G; Sachs C
    Med Biol; 1976 Aug; 54(4):286-97. PubMed ID: 8670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.